12.00
+0.05
+(0.42%)
At close: January 10 at 8:05:25 AM GMT+1
Research Analysis
Earnings Estimate
| Currency in USD | Current Qtr. (Dec 2024) | Next Qtr. (Mar 2025) | Current Year (2024) | Next Year (2025) |
|---|---|---|---|---|
| No. of Analysts | -- | -- | -- | -- |
| Avg. Estimate | 0 | 0 | 0 | 0 |
| Low Estimate | 0 | 0 | 0 | 0 |
| High Estimate | 0 | 0 | 0 | 0 |
| Year Ago EPS | -- | -- | -- | -- |
Revenue Estimate
| Currency in USD | Current Qtr. (Dec 2024) | Next Qtr. (Mar 2025) | Current Year (2024) | Next Year (2025) |
|---|---|---|---|---|
| No. of Analysts | 9 | 6 | 11 | 11 |
| Avg. Estimate | 4.44M | 3.69M | 15.7M | 49.42M |
| Low Estimate | 2.9M | 2.97M | 14M | 27.03M |
| High Estimate | 6.84M | 5M | 18M | 66.7M |
| Year Ago Sales | 4.53M | 2.97M | 17.49M | 15.7M |
| Sales Growth (year/est) | -1.98% | 24.17% | -10.21% | 214.76% |
EPS Trend
| Currency in USD | Current Qtr. (Dec 2024) | Next Qtr. (Mar 2025) | Current Year (2024) | Next Year (2025) |
|---|---|---|---|---|
| Current Estimate | 0 | 0 | 0 | 0 |
| 7 Days Ago | 0 | 0 | 0 | 0 |
| 30 Days Ago | 0 | 0 | 0 | 0 |
| 60 Days Ago | 0 | 0 | 0 | 0 |
| 90 Days Ago | 0 | 0 | 0 | 0 |
EPS Revisions
| Currency in USD | Current Qtr. (Dec 2024) | Next Qtr. (Mar 2025) | Current Year (2024) | Next Year (2025) |
|---|---|---|---|---|
| Up Last 7 Days | -- | -- | -- | -- |
| Up Last 30 Days | -- | -- | -- | -- |
| Down Last 7 Days | -- | -- | -- | -- |
| Down Last 30 Days | -- | -- | -- | -- |
Growth Estimates
| Current Qtr. | Next Qtr. | Current Year | Next Year | |
|---|---|---|---|---|
| LT4.F | -- | -- | -- | -- |
| S&P 500 | 8.70% | 11.55% | 14.03% | 13.42% |
Upgrades & Downgrades
| Initiated | Scotiabank: Sector Outperform | 10/16/2024 |
| Initiated | LifeSci Capital: Outperform | 10/3/2024 |
| Reiterates | HC Wainwright & Co.: Buy to Buy | 8/23/2024 |
| Reiterates | Needham: Buy to Buy | 8/22/2024 |
| Maintains | BTIG: Buy to Buy | 8/20/2024 |
| Maintains | B of A Securities: Buy to Buy | 8/20/2024 |
Related Tickers
UR9.SG Clinuvel Pharmaceuticals Ltd
6.87
+0.73%
1JK.F Apellis Pharmaceuticals, Inc.
30.75
-1.76%
U5P.SG Vivani Medical Inc
1.1500
0.00%
ASEP.CN ASEP Medical Holdings Inc.
0.0500
0.00%
PI3.F Gubra A/S
86.60
-3.56%
CYCCP Cyclacel Pharmaceuticals, Inc.
7.60
-3.55%
GYRE Gyre Therapeutics, Inc.
9.99
+3.85%
UPB Upstream Bio, Inc.
13.70
-15.38%
NTRB Nutriband Inc.
4.1300
-3.28%
TYRA Tyra Biosciences, Inc.
15.20
-4.82%